₹68.9
▼ -2.76 -3.85%
17 Jul 2026
NSE Listed · Pharmaceuticals
Alpa Laboratories Ltd. (ALPA)
Volume: 805Avg Vol 1W: 8,921Avg Vol 1M: 12,18352W Range:₹46.1₹105.9
Key Ratios
Checked just nowMarket Cap₹145 Cr
Current Price₹68.9
Previous Close₹71.66
High / Low (52w)₹105.9 / ₹46.1
Volume805
Avg Vol (1W)8,921
Avg Vol (1M)12,183
Stock P/E287.08
Book Value₹88.53
Dividend Yield0%
ROE8.06%
ROA6.13%
Revenue (TTM)—
Revenue Growth3.41%
Profit Margin14.03%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹7.13
P/B0.78
Debt / Equity0.02
50 DMA₹68.88
200 DMA₹66.59
Day change-3.85%
Price Chart
₹68.9▼ 13.33% · 1Y
2025-11-212026-07-16
20-day avg volume: 13K shares
Pros
- Company is almost debt-free.
- Net profit is growing year over year.
- Stock trades below its book value.
Cons
- Stock trades at a high P/E of 287.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹21 Cr | ₹25 Cr | ₹26 Cr | ₹40 Cr | ₹19 Cr | ₹26 Cr | ₹29 Cr | ₹31 Cr |
| EBITDA | ₹5 Cr | ₹10 Cr | ₹9 Cr | ₹2 Cr | ₹12 Cr | ₹0 Cr | ₹2 Cr | ₹3 Cr |
| Net Profit | ₹5 Cr | ₹8 Cr | ₹9 Cr | ₹-2 Cr | ₹12 Cr | ₹0 Cr | ₹2 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹68 Cr | ₹83 Cr | ₹89 Cr | ₹102 Cr | ₹123 Cr | ₹102 Cr | ₹124 Cr | ₹136 Cr |
| EBITDA | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹11 Cr | ₹20 Cr | ₹16 Cr | ₹21 Cr | ₹26 Cr |
| Net Profit | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹7 Cr | ₹14 Cr | ₹13 Cr | ₹17 Cr | ₹20 Cr |
| EPS | 1.33 | 0.48 | 0.89 | 3.45 | 6.7 | 5.88 | 8.01 | 9.34 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹122 Cr | ₹121 Cr | ₹121 Cr | ₹140 Cr | ₹155 Cr | ₹167 Cr | ₹182 Cr | ₹223 Cr |
| Total Liabilities | ₹24 Cr | ₹23 Cr | ₹21 Cr | ₹33 Cr | ₹34 Cr | ₹33 Cr | ₹30 Cr | ₹51 Cr |
| Equity | ₹98 Cr | ₹98 Cr | ₹100 Cr | ₹108 Cr | ₹122 Cr | ₹135 Cr | ₹152 Cr | ₹171 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹-11 Cr | ₹1 Cr | ₹19 Cr | ₹1 Cr | ₹13 Cr | ₹12 Cr | ₹7 Cr | ₹22 Cr |
| Investing | ₹-11 Cr | ₹-15 Cr | ₹-11 Cr | ₹6 Cr | ₹-16 Cr | ₹2 Cr | ₹-13 Cr | ₹-12 Cr |
| Financing | ₹9 Cr | ₹-5 Cr | ₹-1 Cr | ₹0 Cr | ₹5 Cr | ₹-4 Cr | ₹3 Cr | ₹-5 Cr |
| Free Cash Flow | ₹-11 Cr | ₹1 Cr | ₹19 Cr | ₹1 Cr | ₹13 Cr | ₹13 Cr | ₹7 Cr | ₹22 Cr |
Shareholding
Promoter 57.19% Institutions 0.42% Public 42.39%
Efficiency & Working Capital
ROCE9%
Interest Coverage112.6
Dividend Payout—
Debtor Days152 d
Inventory Days57 d
Payable Days61 d
Cash Conversion Cycle149 d
Working Capital Days209 d
Shareholding Details
As of 2026-06-30
Promoter57.2%
FII0.4%
DII0.1%
Institutions0.4%
Public42.4%
Promoter Pledge0%
No. of Shareholders17,643
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 57.3% | 57.3% | 57.3% | 57.3% | 57.3% | 57.3% | 57.3% | 57.3% | 57.3% | 57.3% | 57.2% | 57.2% |
| FIIs | 0.1% | 1% | 0.5% | 0.4% | 0.7% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.1% |
| Public | 42.6% | 41.8% | 42.2% | 42.3% | 42% | 42.4% | 42.3% | 42.3% | 42.4% | 42.3% | 42.4% | 42.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 18,565 | 18,682 | 18,690 | 18,116 | 18,885 | 19,206 | 18,872 | 18,851 | 18,542 | 18,236 | 17,900 | 17,643 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Paresh Chawla | Shareholding of Promoter and Promoter Group | 34.3% | 72,08,210 |
| Shitul Shah | Shareholding of Promoter and Promoter Group | 10.2% | 21,34,780 |
| Bakulesh Shah | Shareholding of Promoter and Promoter Group | 4.9% | 10,26,600 |
| Rima Shah | Shareholding of Promoter and Promoter Group | 3.7% | 7,75,200 |
| Rupal Shah | Shareholding of Promoter and Promoter Group | 2.7% | 5,58,780 |
| Soni Chawla | Shareholding of Promoter and Promoter Group | 1.6% | 3,26,800 |
| Pravin Shah | Shareholding of Promoter and Promoter Group | 0% | 1,000 |
| Mahendra Singh Chawla | Shareholding of Promoter and Promoter Group | 0% | 1,000 |
| Asha Chawla | Shareholding of Promoter and Promoter Group | 0% | 700 |
| Pooja Chawla | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Meeta Sethi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mitin Shah | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Saraswati Shah | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bakulesh Chandulal Shah Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Mahendra Singh Chawla | 0 | 0% | 2026-06-30 |
| Asha Chawla | 0 | 0% | 2026-06-30 |
| Paresh Chawla | 0 | 0% | 2026-06-30 |
| Soni Chawla | 0 | 0% | 2026-06-30 |
| Pravin Shah | 0 | 0% | 2026-06-30 |
| Bakulesh Shah | 0 | 0% | 2026-06-30 |
| Rupal Shah | 0 | 0% | 2026-06-30 |
| Shitul Shah | 0 | 0% | 2026-06-30 |
| Rima Shah | 0 | 0% | 2026-06-30 |
| Pooja Chawla | 0 | 0% | 2026-06-30 |
| Meetha Sethi | 0 | 0% | 2026-06-30 |
| Mitin Shah | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Mahendra Singh Chawla | Chairman & Exec. Director | 2025 |
| Vitthal Kothana | E D & Wholetime Director | 2025 |
| Paresh Chawla | ED / MD / Promoter | 2025 |
| Pravin C Shah | WTD & Executive Director | 2025 |
| Shitul Shah | WTD & Executive Director | 2025 |
| Pratik Shah | Independent Non Exe. Director | 2025 |
| Jyoti Jain | Independent Non Exe. Director | 2025 |
| BAHETI SANKET | Independent Non Exe. Director | 2025 |
| Sunil Valecha | Independent Non Exe. Director | 2025 |
| Pratibha Lunawat | Independent Non Exe. Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Drugs and chemicals | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Outside India | ₹20 Cr | 31.1% |
| Within India | ₹45 Cr | 68.9% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 21 | 21 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 5 | 1 | 6 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
| 2025 | 0 | 0 | 0 | 5 | 0 | 6 |
Insider / Designated-Person Trades
12 recent disclosure(s)
VINIT SHAHAcquisition · 21,940
BAKULESH CHANDULAL SHAH HUFDisposal · 21,940
Shitul ShahAcquisition · 11,00,580
Pravin ShahDisposal · 11,00,580
Shitul ShahAcquisition · 1,09,000
Pravin ShahDisposal · 1,09,000
Substantial Acquisitions (SAST)
13 disclosure(s)
Off Market25/06/2025 · 11,00,580
-25/06/2025 · 11,00,580
Off Market25/06/2025 · 11,00,580
Off Market16/06/2025 · 1,09,000
-16/06/2025 · 1,09,000
Off Market16/06/2025 · 1,09,000
Company Information
🌐 www.alpalabs.in ↗
📍 33/2 Pigdamber, A B Road Rau, Indore, Madhya Pradesh, 453446
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search